Management of tumour lysis syndrome in children: What is the evidence for prophylactic rasburicase in non-hyperleucocytic leukaemia?

British Journal of Haematology

Volumn 153, Issue 2, 2011, Pages 275-277

  Agrawal, Anurag K ^a   Feusner, James H ^a  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

Author keywords

Acute lymphoblastic leukaemia; Acute myeloid leukaemia; Paediatric oncology

Indexed keywords

LACTATE DEHYDROGENASE; RASBURICASE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; CHILD; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG SAFETY; EVIDENCE BASED MEDICINE; HUMAN; LETTER; LEUKOCYTE COUNT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; SINGLE DRUG DOSE; TUMOR LYSIS SYNDROME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GOUT SUPPRESSANTS; HUMANS; INFANT; LEUKEMIA, MYELOID, ACUTE; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TUMOR LYSIS SYNDROME; URATE OXIDASE;

EID: 79953081631     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08506.x     Document Type: Letter

References (8)

1. Bertrand, Y., Mechinaud, F., Brethon, B., Mialou, V., Auvrignon, A., Nelken, B., Notz-Carrère, A., Plantaz, D., Patte, C., Urbieta, M., Baruchel, A. & Leverger, G. (2008) SFCE (Société Française de Lutte contre les Cancers et Leucémias de l'Enfant et de l'Adolescent) recommendations for the management of tumor lysis syndrome (TLS) with rasburicase: an observational study. Journal of Pediatric Hematology/Oncology, 30, 267-271.
2. Cairo, M.S. & Bishop, M. (2004) Tumour lysis syndrome: new therapeutic strategies and classification. British Journal of Haematology, 127, 3-11.
3. Cairo, M.S., Coiffier, B., Reiter, A. & Younes, A. (2010) Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. British Journal of Haematology, 149, 578-586.
4. Coiffier, B., Altman, A., Pui, C.H., Younes, A. & Cairo, M.S. (2008) Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. Journal of Clinical Oncology, 26, 2767-2778.
5. Knoebel, R., Lo, M. & Crank, C. (2010) Evaluation of a low, weight-based dose of rasburicase in adult patients for the treatment or prophylaxis of tumor lysis syndrome. Journal of Oncology Pharmacy Practice, [Epub 2010 Mar 23].
6. Montesinos, P., Lorenzo, I., Martín, G., Sanz, J., Pérez-Sirvent, M.L., Martínez, D., Ortí, G., Algarra, L., Martínez, J., Moscardó, F., de la Rubia, J., Jarque, I., Sanz, G. & Sanz, M.A. (2008) Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model. Haematologica, 93, 67-74.
7. Tosi, P., Barosi, G., Lazzaro, C., Liso, V., Marchetti, M., Morra, E., Pession, A., Rosti, G., Santoro, A., Zinzani, P.L. & Tura, S. (2008) Consensus conference on the management of tumor lysis syndrome. Haematologica, 93, 1877-1885.
8. Truong, T.H., Beyene, J., Hitzler, J., Abla, O., Maloney, A.M., Weitzman, S. & Sung, L. (2007) Features at presentation predict children with acute lymphoblastic leukemia at low risk for tumor lysis syndrome. Cancer, 110, 1832-1839.